BioLife Solutions BLFS Gain (loss) on available-for-sale debt securities
Gain (loss) on available-for-sale debt securities at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's gain (loss) on available-for-sale debt securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's gain (loss) on available-for-sale debt securities?
- BioLife Solutions (BLFS) reported gain (loss) on available-for-sale debt securities of -$252K in Q1 2026.
- How has BioLife Solutions's gain (loss) on available-for-sale debt securities changed year-over-year?
- BioLife Solutions's gain (loss) on available-for-sale debt securities decreased by 2700.0% year-over-year, from -$9K to -$252K.
- What does gain (loss) on available-for-sale debt securities mean?
- Reflects the change in the fair market value of debt securities held by the company that have not yet been sold. This non-cash adjustment accounts for market fluctuations in the company's investment portfolio, impacting the carrying value of assets on the balance sheet. It is essential for assessing the volatility and risk profile of the company's treasury and investment management activities.